2-S-benzyl substituted pyrimidines as CRTH2 antagonists
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 20, 2012
Grant Date -
Sep 23, 2010
app pub date -
Sep 24, 2008
filing date -
Sep 25, 2007
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Provided herein are 2-S-benzyl pyrimidine compounds having CRTH2 (G-protein-coupled chemoattractant receptor, expressed on Th2 cells) antagonistic activity, useful for the prophylaxis and treatment of diseases associated with CRTH2 activity, including the treatment of allergic diseases, eosinophil-related diseases and basophil-related diseases.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully